Reference
D'Alessandris QG, et al. Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experience. Acta Neurochirurgica 155: 33-40, No. 1, Jan 2013. Available from: URL: http://dx.doi.org/10.1007/s00701-012-1536-5 - Italy
Rights and permissions
About this article
Cite this article
Bevacizumab/erlotinib. Reactions Weekly 1451, 11 (2013). https://doi.org/10.1007/s40278-013-2913-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-2913-4